Stroke, Vol 19, 1411-1419, Copyright © 1988 by American Heart Association
DR LeMay, L Gehua, GB Zelenock and LG D'Alecy
Hyperglycemia exacerbates neurologic damage in clinical and experimental
central nervous system ischemia. The purpose of our study was to determine
if insulin administration before significantly alters neurologic deficit
and survival after ischemia using a newly developed rat cerebral ischemia
model. One hour before the onset of ischemia, 40 200-300-g Sprague-Dawley
rats received intraperitoneal injections of either 1 ml normal saline or
0.4, 0.5, or 0.6 units regular insulin in 1 ml normal saline. Rats were
then intubated and ventilated with 1-1.5% halothane. The aortic arch was
exposed, and snares were placed on the innominate, left carotid, and left
subclavian arteries. A 20-minute occlusion was begun, and anesthesia was
discontinued. Baseline plasma glucose concentration was similar (p = 0.48,
Student's t test) in both groups, but it subsequently was significantly
lower in the 0.4 unit insulin-treated group up to 4 hours after occlusion
(p less than or equal to 0.0035, Student's t test). Neurologic deficit was
scored on a 50-point scale (0 = normal, 50 = severe deficit) 1, 4, 18, and
24 hours after occlusion. In the 0.4 unit insulin-treated group the
neurologic deficit score was significantly lower than in the saline-treated
group 1, 4, 18, and 24 hours after occlusion (p less than or equal to
0.005, Student's t test). Survival was significantly higher (p = 0.001) in
the 0.4 unit insulin-treated (1.7 unit/kg dose) group than in the saline-
treated group. No rats died when preocclusion plasma glucose concentration
was between 65 and 175 mg/dl.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Insulin administration protects neurologic function in cerebral ischemia in rats
Department of Physiology and Surgery, University of Michigan Medical School, Ann Arbor 48109.
This article has been cited by other articles:
![]() |
D. W. Quinn, D. Pagano, R. S. Bonser, S. J. Rooney, T. R. Graham, I. C. Wilson, B. E. Keogh, J. N. Townend, M. E. Lewis, P. Nightingale, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 34 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Makkad and S. Pilling Management of Thoracic Aneurysm Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2005; 9(3): 227 - 240. [Abstract] [PDF] |
||||
![]() |
L. L. Guyot, F. G. Diaz, M. H. O'regan, D. Song, and J. W. Phillis Topical Insulin and Accumulation of Excitotoxic and Other Amino Acids in Ischemic Rat Cerebral Cortex Experimental Biology and Medicine, May 1, 2000; 224(1): 28 - 31. [Abstract] [Full Text] |
||||
![]() |
R. E. Anderson, W. K. Tan, H. S. Martin, F. B. Meyer, and P. D. Hurn Effects of Glucose and PaO2 Modulation on Cortical Intracellular Acidosis, NADH Redox State, and Infarction in the Ischemic Penumbra • Editorial Comment Stroke, January 1, 1999; 30(1): 160 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Tyson, G. R. Sutherland, and J. Peeling 23Na Nuclear Magnetic Resonance Spectral Changes During and After Forebrain Ischemia in Hypoglycemic, Normoglycemic, and Hyperglycemic Rats Stroke, May 1, 1996; 27(5): 957 - 964. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |